Managing SMA Patients During the COVID-19 Pandemic – CureSMA


Program Dates: August 15th, 2020 - August 14th, 2021
Credits: 0.50 AMA PRA Category 1 Credits™


Managing SMA Patients During the COVID-19 Pandemic – CureSMA

Program Overview

In this module, Oscar Henry Mayer, MD, along with Claudia Chiriboga, MD, MPH, course chair, will discuss strategies for managing spinal muscular atrophy (SMA) patients during the COVID-19 pandemic. Current clinical recommendations from CureSMA for the management of patients with SMA will be reviewed during the interview segment. Best practices for avoiding care disruption for SMA patients during the COVID-19 pandemic will also be discussed. Upon completion of this 30-minute module, learners will gain insight into the clinical recommendations for managing their SMA patients during the COVID-19 pandemic.

Target Audience

Neurologists, pediatricians, geneticists, primary care physicians, nurses, NPs, PAs, pharmacists, and other healthcare providers involved in the management of patients with SMA

Learning Objective

  1. Review current clinical recommendations from CureSMA for the management of patients with SMA, with attention to avoiding care disruption during the COVID-19 pandemic

Faculty

Claudia A. Chiriboga, MD, MPH
Professor of Neurology
Columbia University
New York, NY

 

 

Oscar Henry Mayer, MD
Medical Director, Pulmonary Function Testing Laboratory
Division of Pulmonology
The Children’s Hospital of Philadelphia
Professor of Clinical Pediatrics
The Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA

 

Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty Relationship Identified With:

Claudia A. Chiriboga, MD, MPH

 

Consultant/Advisor: AveXis, Inc.; Biogen; Cytokinetics, Inc.; F. Hoffmann-La Roche Ltd.

Grant/Research Support: AveXis, Inc.; Biogen; F. Hoffmann-La Roche Ltd.

Speaker’s Bureau: Biogen

Oscar Henry Mayer, MD Consultant/Advisor: Biogen

Speaker’s Bureau: Biogen

 

Planners and Peer Reviewers

Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Nicole McMenamin and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team.

Credit Designation Statements

AcademicCME designates this live material for a maximum of 0.50 AMA PRA Category 1 Credits TM.

Participants should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Biogen

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Biogen do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Learners who receive a grade of 66% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
  • CPE credit will be posted to the learner’s CPE Monitor profile within 60 days of completion.
  • CME and CNE credit will be issued appropriate certificate of completion.
  • Others may request a “certificate of completion”.
  1. Learners should claim only the credit commensurate with the extent of their participation in the activity.

CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact [email protected].

BUTTON

 

 

Provided by: AcademicCME-web